Document Type

Article

Publication Date

3-2-2016

Keywords

Cancer therapy, Nanoparticles

Digital Object Identifier (DOI)

https://doi.org/10.1038/srep22478

Abstract

The most common cancer treatments currently available are radio- and chemo-therapy. These therapies have, however, drawbacks, such as, the reduction in quality of life and the low efficiency of radiotherapy in cases of multiple metastases. To lessen these effects, we have encapsulated an anti-cancer drug into a biocompatible matrix. In-vitro assays indicate that this bio-nanocomposite is able to interact and cause morphological changes in cancer cells. Meanwhile, no alterations were observed in monocytes and fibroblasts, indicating that this system might carry the drug in living organisms with reduced clearance rate and toxicity. X-rays and neutrons were used to investigate the carrier structure, as well as to assess the drug mobility within the bio-nanocomposite. From these unique data we show that partial mobility restriction of active groups of the drug molecule suggests why this carrier design is potentially safer to healthy cells.

Rights Information

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Was this content written or created while at USF?

Yes

Citation / Publisher Attribution

Scientific Reports, v. 6, art. 22478

Supplementary information.pdf (1968 kB)
Supplementary information

Supplementary Movie S1.mov (1018 kB)
Movie S1

Supplementary Movie S2.mov (864 kB)
Movie S2

Supplementary Movie S3.mov (1056 kB)
Movie S3

Supplementary Movie S4.mov (895 kB)
Movie S4

Supplementary Movie S5.mov (688 kB)
Movie S5

Supplementary Movie S6.mov (692 kB)
Movie S6

Supplementary Movie S7.mov (888 kB)
Movie S7

Supplementary Movie S8.mov (544 kB)
Movie S8

Supplementary Movie S9.mov (567 kB)
Movie S9

Included in

Chemistry Commons

Share

COinS